Immuno-effect of Tα1 for Stage I NSCLC
NCT06598839
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Non Small Cell Lung Cancer
Interventions
DRUG:
Thymosin Alpha1
Sponsor
Yousheng Mao